James West from the Midas Letter visited Supreme Pharmaceuticals (TSXV:FIRE) CEO John Fowler at the company’s 7Acres facility.

James West from the Midas Letter visited Supreme Pharmaceuticals (TSXV:FIRE) CEO John Fowler at the company’s 7Acres facility. During the video, Fowler presented the harvest-ready ready crop of Supreme’s Wappa 21 strain, expected to have a range of 18-20 percent THC.
“We have a commitment to be a premium flower cultivator,” said Fowler, also explaining that they are becoming prepared for the rollout of recreational use in Canada come July 2018. He explained that while the proportional use of dried flower might be shrinking, it is still a growing market in terms of dollars spent, which is why Supreme will continue focusing on flower production.
Fowler also explained the company’s phenotyping methods, which are focused on perfecting the crops so that they are producing premium product on a consistent basis for both the medical and recreational markets.
To watch the video, click here.
Click here to connect with Supreme Pharmaceuticals (TSXV:FIRE) for an Investor Presentation